Objectives. The purpose of this study was to characterize, by use of the Ep
pendorf microelectrode, the extent of hypoxia (range/heterogeneity) in huma
n prostate carcinomas,
Methods. Custom-made Eppendorf pO(2) microelectrodes were used to obtain pO
(2) measurements from the pathologically involved side of the prostate, as
well as from a region of normal muscle for comparison. Each set of measurem
ents comprised approximately 100 separate readings of pO(2), for a total of
2145 individual measurements. Twelve patients were studied, 7 of whom unde
rwent brachytherapy, 3 a radical prostatectomy, and 2 a cystoprostatectomy.
The pO(2) measurements were obtained in the operating room, using sterile
technique, under spinal anesthesia for the brachytherapy group patients and
under general anesthesia for the surgery group patients. The Eppendorf his
tograms were recorded and described by the median pO(2), mean pO(2), and pe
rcentage of measurements less than 5 mm Hg and less than 10 mm Hg.
Results, Because of differences in patient characteristics and the anesthes
ia employed, control measurements were obtained from nearby normal muscle a
s an internal control in all but 2 patients. This internal comparison showe
d that the oxygen measurements from the pathologically involved portion of
the prostate were significantly lower than those from normal muscle. Simila
rly, higher pO(2) readings were obtained from the pathologically normal pro
states (in the patients with bladder cancer) than from the prostates of pat
ients with prostate carcinoma. Increasing levels of hypoxia were observed w
ith increasing clinical stage. Significant predictors of oxygenation includ
e the type of tissue (pathologically involved prostate versus normal muscle
or normal prostate), clinical stage, and type of anesthesia.
Conclusions. This report, to our knowledge, represents the first study to o
btain in vivo electrode measurements of oxygen levels in patients with pros
tate cancer and suggests that hypoxic regions exist in human prostate carci
noma. More patients will be accrued to this prospective study to correlate
the oxygenation status of prostate carcinoma with known prognostic factors
and treatment outcome. UROLOGY 53: 11-18, 1999. (C) 1999, Elsevier Science
Inc. All rights reserved.